These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1311 related articles for article (PubMed ID: 8630372)

  • 1. Biologic basis for interleukin-1 in disease.
    Dinarello CA
    Blood; 1996 Mar; 87(6):2095-147. PubMed ID: 8630372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 and its inhibitors: implications for disease biology and therapy.
    Estrov Z; Kurzrock R; Talpaz M
    Cancer Treat Res; 1995; 80():51-82. PubMed ID: 8821574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
    Dinarello CA
    Int Rev Immunol; 1998; 16(5-6):457-99. PubMed ID: 9646173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1.
    Dinarello CA
    Cytokine Growth Factor Rev; 1997 Dec; 8(4):253-65. PubMed ID: 9620641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The balance between IL-1 and IL-1Ra in disease.
    Arend WP
    Cytokine Growth Factor Rev; 2002; 13(4-5):323-40. PubMed ID: 12220547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal links between brain cytokines and experimental febrile convulsions in the rat.
    Heida JG; Pittman QJ
    Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1beta and of the type I and type II IL-1 receptors.
    Kol S; Ruutiainen-Altman K; Scherzer WJ; Ben-Shlomo I; Ando M; Rohan RM; Adashi EY
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):115-28. PubMed ID: 10375024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias.
    Kurzrock R; Wetzler M; Estrov Z; Talpaz M
    Cytokines Mol Ther; 1995 Sep; 1(3):177-84. PubMed ID: 9384674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor antagonist.
    Lennard AC
    Crit Rev Immunol; 1995; 15(1):77-105. PubMed ID: 8519423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
    Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
    Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from interleukin-deficient mice: the interleukin-1 system.
    Fantuzzi G
    Acta Physiol Scand; 2001 Sep; 173(1):5-9. PubMed ID: 11678721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-1 axis and cutaneous inflammation.
    Kupper TS; Groves RW
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):62S-66S. PubMed ID: 7615999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of IL-1ra gene up-regulates interleukin-1beta converting enzyme (ICE) gene expression: possible mechanism underlying IL-1beta-resistance of cancer cells.
    Sumitomo M; Tachibana M; Murai M; Hayakawa M; Nakamura H; Takayanagi A; Shimizu N
    Br J Cancer; 1999 Sep; 81(2):277-86. PubMed ID: 10496353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo.
    Klueh U; Antar O; Qiao Y; Kreutzer DL
    J Diabetes Sci Technol; 2013 Nov; 7(6):1538-46. PubMed ID: 24351180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist.
    Arend WP
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):1-6. PubMed ID: 11357165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and IL-1beta-stimulated cytokine and neuropeptide mRNA expression in brain regions of young and old Long-Evans rats.
    Gayle D; Ilyin SE; Romanovitch AE; Peloso E; Satinoff E; Plata-Salamán CR
    Brain Res Mol Brain Res; 1999 Jun; 70(1):92-100. PubMed ID: 10381547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.
    Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE
    Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoregulation of the interleukin-1 system and cytokine-cytokine interactions in primary human astrocytoma cells.
    Ilyin SE; González-Gómez I; Romanovicht A; Gayle D; Gilles FH; Plata-Salamán CR
    Brain Res Bull; 2000 Jan; 51(1):29-34. PubMed ID: 10654577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.
    Somm E; Cettour-Rose P; Asensio C; Charollais A; Klein M; Theander-Carrillo C; Juge-Aubry CE; Dayer JM; Nicklin MJ; Meda P; Rohner-Jeanrenaud F; Meier CA
    Diabetologia; 2006 Feb; 49(2):387-93. PubMed ID: 16385385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade.
    Stewart RJ; Marsden PA
    Am J Kidney Dis; 1995 Jun; 25(6):954-66. PubMed ID: 7771496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.